The Ministry of Health and Welfare selects Johnson & Johnson’s JLABS to operate the country’s global accelerator platform. JLABS will engage with various local incubators and collaborators in the startup ecosystem to offer venture development programs, stimulate employment and encourage commercialization to enhance the global competitiveness of Korea’s life sciences sector.
Costa Rica revises its biotech regulatory framework to ease restrictions on gene editing and other new breeding techniques. Experts say a banana variety resistant to yield-reducing fungal diseases sigatoka and Fusarium wilt could be the first genome-edited product commercialized in Costa Rica later this year.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
209,00 € per year
only 17,42 € per issue
Buy this article
Purchase on Springer LinkInstant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Log in
Learn about institutional subscriptions
Read our FAQs
Contact customer support
About this article
Cite this article
Biotech news from around the world.
Nat Biotechnol42, 544 (2024). https://doi.org/10.1038/s41587-024-02216-0
Download citation
Published: 17 April 2024
Issue Date: April 2024
DOI: https://doi.org/10.1038/s41587-024-02216-0
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Nature.com – https://www.nature.com/articles/s41587-024-02216-0
